Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin Replacement with Alfapump in Refractory Ascites
NCT02448160Terminated
- Sponsor
- Sequana Medical
- Start
- Jan 2016
- Primary completion
- Dec 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of albumin (human) in Liver cirrhosis (LC), sponsored by Sequana Medical. Primary endpoint: Development of renal dysfunction at 3 months. Started Jan 2016; status: terminated.
02
Drugs
albumin (human)
03
Conditions
Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT02448160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02448160.